tetano
Editor, Senior Moderator
Vaccine
. 2020 Nov 24;S0264-410X(20)31494-8.
doi: 10.1016/j.vaccine.2020.11.041. Online ahead of print.
Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines
Anu Haveri[SUP] 1 [/SUP], Niina Ikonen[SUP] 2 [/SUP], Carita Savolainen-Kopra[SUP] 2 [/SUP], Ilkka Julkunen[SUP] 3 [/SUP]
Affiliations
Abstract
Background: Avian influenza A(H5N1) viruses have caused sporadic infections in humans and thus they pose a significant global health threat. Among symptomatic patients the case fatality rate has been ca. 50%. H5N1 viruses exist in multiple clades and subclades and several candidate vaccines have been developed to prevent A(H5N1) infection as a principal measure for preventing the disease.
Methods: Serum antibodies against various influenza A(H5N1) clade viruses were measured in adults by ELISA-based microneutralization and haemagglutination inhibition tests before and after vaccination with two different A(H5N1) vaccines in 2009 and 2011.
Results: Two doses of AS03-adjuvanted A/Indonesia/5/2005 vaccine induced good homologous but poor heterologous neutralizing antibody responses against different clade viruses. However, non-adjuvanted A/Vietnam/1203/2004 booster vaccination in 2011 induced very strong and long-lasting homologous and heterologous antibody responses while homologous response remained weak in na?ve subjects.
Conclusions: Sequential vaccination with two different A(H5N1) pre-pandemic vaccines induced long-lasting high level cross-clade immunity against influenza A(H5N1) strains, thus supporting a prime-boost vaccination strategy in pandemic preparedness plans.
Keywords: Antibodies; Humoral immunity; Influenza A(H5N1); Microneutralization test; Pre-pandemic vaccine.
. 2020 Nov 24;S0264-410X(20)31494-8.
doi: 10.1016/j.vaccine.2020.11.041. Online ahead of print.
Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines
Anu Haveri[SUP] 1 [/SUP], Niina Ikonen[SUP] 2 [/SUP], Carita Savolainen-Kopra[SUP] 2 [/SUP], Ilkka Julkunen[SUP] 3 [/SUP]
Affiliations
- PMID: 33246672
- DOI: 10.1016/j.vaccine.2020.11.041
Abstract
Background: Avian influenza A(H5N1) viruses have caused sporadic infections in humans and thus they pose a significant global health threat. Among symptomatic patients the case fatality rate has been ca. 50%. H5N1 viruses exist in multiple clades and subclades and several candidate vaccines have been developed to prevent A(H5N1) infection as a principal measure for preventing the disease.
Methods: Serum antibodies against various influenza A(H5N1) clade viruses were measured in adults by ELISA-based microneutralization and haemagglutination inhibition tests before and after vaccination with two different A(H5N1) vaccines in 2009 and 2011.
Results: Two doses of AS03-adjuvanted A/Indonesia/5/2005 vaccine induced good homologous but poor heterologous neutralizing antibody responses against different clade viruses. However, non-adjuvanted A/Vietnam/1203/2004 booster vaccination in 2011 induced very strong and long-lasting homologous and heterologous antibody responses while homologous response remained weak in na?ve subjects.
Conclusions: Sequential vaccination with two different A(H5N1) pre-pandemic vaccines induced long-lasting high level cross-clade immunity against influenza A(H5N1) strains, thus supporting a prime-boost vaccination strategy in pandemic preparedness plans.
Keywords: Antibodies; Humoral immunity; Influenza A(H5N1); Microneutralization test; Pre-pandemic vaccine.